Description
CYANOFOLIN FAST
Description
Vitamin and mineral supplements.
Folic acid, vitamin B12 and vitamin B6 contribute to normal homocysteine metabolism.
In addition, vitamin B12 and vitamin B6 contribute to the normal functioning of the nervous system.
With sweetener and no added sugars.
Ingredients
Bulking agent: D-mannitol, corn starch (Pearlitol Flash); vitamin B6 (pyridoxine hydrochloride); xylitol; anti-caking agents: magnesium salts of fatty acids; flavouring; folic acid (pteroylmonoglutamic acid); sweetener: sucralose; vitamin B12 (cyanocobalamin).
Gluten free.
Naturally lactose free.
Nutritional characteristics
*NRV: Nutrient Reference Values for adults, EU Reg. 1169/2011.
How to use
Take 1 tablet per day, to be dissolved in the mouth until completely dissolved; preferably away from meals.
Warnings
Supplements are not intended as a substitute for a varied, balanced diet and a healthy lifestyle. Do not exceed the recommended doses. Keep out of reach of children under three years of age. Do not take in case of hypersensitivity or allergies to one or more components.
Conservation
Store in a cool, dry place, at a temperature not exceeding 25-30°C, away from light and/or heat sources. The minimum shelf life refers to the product correctly stored in its intact packaging.
Validity with intact packaging : 36 months.
Format
Case containing 30 orodispersible tablets of 200 mg.
Net weight 6.0 g.
Code 289
Any supporting studies and bibliography:
Herrmann W, Herrmann M, Obeid R. Hyperhomocysteinemia: a critical review of old and new aspects. Curr Drug Metab. 2007 Jan;8(1):17-31.
- Villa P et al. Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation. Clin Chem Lab Med. 2007;45(2):130-135.
- Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med. 2007 Jun;131(6):872- 84.
- Herrmann W. Significance of hyperhomocysteinemia. Clin Lab. 2006;52(7-8):367-374.
- Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr. 2006 Jun;136(6 suppl):1726-1730.
-Lonn E et al. Homocysteine lowering with folic acid and b vitamins in vascular disease. N Engl J Med. 2006 Apr; 13-354(15):1567-77.
- Toole JF et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004 Feb 4;291(5):565-75.
-Chambers JC et al. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000;102:2479-83.
- Jolien de Jager et al. Long-term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomized placebo-controlled trial. BMJ, 2010, 340.
- Lam JR. et al. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013 Dec 11;310(22):2435-42.
Vitamin and mineral supplements.
Folic acid, vitamin B12 and vitamin B6 contribute to normal homocysteine metabolism.
In addition, vitamin B12 and vitamin B6 contribute to the normal functioning of the nervous system.
With sweetener and no added sugars.
Ingredients
Bulking agent: D-mannitol, corn starch (Pearlitol Flash); vitamin B6 (pyridoxine hydrochloride); xylitol; anti-caking agents: magnesium salts of fatty acids; flavouring; folic acid (pteroylmonoglutamic acid); sweetener: sucralose; vitamin B12 (cyanocobalamin).
Gluten free.
Naturally lactose free.
Nutritional characteristics
| Medium Contents | for 1 tablet |
| Folic acid | 400 mcg (200% NRV*) |
| Vitamin B12 | 50 mcg (2,000% NRV*) |
| Vitamin B6 | 10 mcg (714% NRV*) |
How to use
Take 1 tablet per day, to be dissolved in the mouth until completely dissolved; preferably away from meals.
Warnings
Supplements are not intended as a substitute for a varied, balanced diet and a healthy lifestyle. Do not exceed the recommended doses. Keep out of reach of children under three years of age. Do not take in case of hypersensitivity or allergies to one or more components.
Conservation
Store in a cool, dry place, at a temperature not exceeding 25-30°C, away from light and/or heat sources. The minimum shelf life refers to the product correctly stored in its intact packaging.
Validity with intact packaging : 36 months.
Format
Case containing 30 orodispersible tablets of 200 mg.
Net weight 6.0 g.
Code 289
Any supporting studies and bibliography:
Herrmann W, Herrmann M, Obeid R. Hyperhomocysteinemia: a critical review of old and new aspects. Curr Drug Metab. 2007 Jan;8(1):17-31.
- Villa P et al. Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation. Clin Chem Lab Med. 2007;45(2):130-135.
- Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med. 2007 Jun;131(6):872- 84.
- Herrmann W. Significance of hyperhomocysteinemia. Clin Lab. 2006;52(7-8):367-374.
- Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr. 2006 Jun;136(6 suppl):1726-1730.
-Lonn E et al. Homocysteine lowering with folic acid and b vitamins in vascular disease. N Engl J Med. 2006 Apr; 13-354(15):1567-77.
- Toole JF et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004 Feb 4;291(5):565-75.
-Chambers JC et al. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000;102:2479-83.
- Jolien de Jager et al. Long-term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomized placebo-controlled trial. BMJ, 2010, 340.
- Lam JR. et al. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013 Dec 11;310(22):2435-42.
